Indeed, treatment of mice harboring Hepa1-6 tumors with the specific VCP inhibitor CB-5083 combined with anti-PD1 suppressed tumor growth without mouse weight loss compared to monotherapy or control groups (Fig. 7b, c and Supplementary Fig. 8a, b). The gene discussed is VCP; the disease is neoplasm.